HC Wainwright Reiterates Buy Rating on CNXU
HC Wainwright maintains its buy rating on CNXU with a $20 target price, a 50.60% upside from the current price.
Key Points
- On June 22, 2026, HC Wainwright reiterated its buy rating on CNXU, setting a price target of $20.
- HC Wainwright's $20 price target implies 50.60% upside from Conexeu Sciences Inc.'s ($CNXU) current $13.28 share price.
- Shares of CNXU traded at $13.28 on Monday, reflecting market interest in the analyst's target.
- The reiterated rating suggests confidence in CNXU's potential, with no insider or peer activity reported.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 22, 2026, HC Wainwright reiterated its buy rating for CNXU, setting a price target of $20. This move by analyst Swayampakula Ramakanth underscores the firm's confidence in the company's future prospects.
HC Wainwright & Co. vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Conexeu Sciences Inc. Stock Up 87.8%
Shares of CNXU traded near $13.28 on Monday. The reiterated buy rating and the $20 target indicate a positive outlook from HC Wainwright, suggesting potential upside from current levels.
$CNXU price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Analysts Set New Price Targets
On June 22, 2026, HC Wainwright & Co. initiated coverage on CNXU with a buy rating and a $20 price target. This reflects a strong belief in the company's growth potential and market position.
Bottom Line
HC Wainwright's reiterated buy rating and $20 target for CNXU highlight the firm's continued confidence in the company's growth trajectory. While the analyst's target suggests room for appreciation, investors should consider this as part of a broader investment strategy. As always, it's important to remember that analyst ratings are based on current information and market conditions.
Get Conexeu Sciences Inc. alerts
New 13F filings, insider trades, and analyst moves on $CNXU, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.